TAVI is a revolutionary, minimally invasive treatment for aortic stenosis (narrowing of the main valve through which the heart pumps to the body), which allows the aortic valve to be replaced without the need for open-heart surgery. Since it was performed in the UK in 2007, TAVI has grown exponentially to become a routine treatment for millions of patients across the world. TAVI is performed under local anaesthetic, and patients can usually be discharged just one or two days after the procedure. The Valve for Life programme aims to improve access to TAVI across the NHS, so that patients can be treated quickly and efficiently, and with equity of access in all parts of the United Kingdom. Elsewhere on this website you can find more detailed information about the TAVI procedure, hear about the experiences of patients who have undergone TAVI, and learn more about the Valve for Life project.
TAVI Patient Information Video
Mitraclip is a minimally invasive procedure used to repair a leaking mitral valve without the need for open-heart surgery.
The procedure is
Less invasive but is carried out using a general anaesthetic
Associated with faster recovery times with patients often returning home 2-3 days after the procedure
Only suitable for certain patients ie those who are ‘high risk’ for standard valve surgery
Unlike the traditional repair surgery, the MitraClip procedure doesn't need the chest to be opened. The doctors access the faulty mitral valve via a catheter (long thin tube) which is fed up to the heart from a vein in the leg.
The Mitraclip device is positioned just below the leaflets of the mitral valve using a steerable guide catheter. Once in position, the two leaflets of the valves are ‘grasped’ by the device, brought closer together in order to reduce or abolish the leak.
The use of Mitraclip has grown significantly over the past decade, with over 80000 patients treated worldwide, and it is the commonest minimally invasive (percutaneous) procedure to treat a leaking mitral valve.
Image by Abbott